Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline

Schmitz, O; Russell-Jones, D; Shaw, J; Brandle, M; Matthews, D; Frid, A; Zdravkovic, M; Garber, A; Zinman, B

Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline

conference contribution

posted on 2023-02-07, 23:17 authored by O Schmitz, D Russell-Jones, J Shaw, M Brandle, D Matthews, A Frid, M Zdravkovic, A Garber, B Zinman

Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline

History

Volume

51

Pagination

S354-S355

Location

ITALY, Rome

Start date

2008-09-07

End date

2008-09-11

ISSN

0012-186X

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000258660201178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Title of proceedings

DIABETOLOGIA

Event

44th Annual Meeting of the European-Association-for-the-Study-of-Diabetes

Publisher

SPRINGER

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism

Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline

History

Volume

Pagination

Location

Start date

End date

ISSN

Language

Author URL

Publication classification

Title of proceedings

Event

Publisher

Usage metrics

Categories

Keywords

Licence

Exports